Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. SNY

Market Cap: $102.7B

SA

Sanofi

SNY
NASDAQ (NASDAQ Global Select)USD
Purchase SNY
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin72.77%
EBITDA Margin16.86%
EBIT Margin12.60%
Pre-tax Margin10.62%
Net Profit Margin8.09%
Earnings Yield4.52%
Valuation Multiples
Price / Book1.27
Price / Sales1.80
Price / Earnings22.40
PEG-0.34
Forward PEG3.28
EV / Sales2.15
EV / EBITDA12.75
EV / Operating Cash Flow6.09
EV / Free Cash Flow6.38
Price / Free Cash Flow5.34
Price / Operating Cash Flow5.08
Cash Flow & Capital
Free Cash Flow / Share$6.89
Operating Cash Flow / Share$7.22
Free Cash Flow Yield18.73%
Capex / Revenue1.62%
Capex / Operating Cash Flow4.59%
Capex / Depreciation0.11
Stock Compensation / Revenue0.00%
Dividend Payout Ratio1.24%
Dividend Yield11.38%
Liquidity & Leverage
Current Ratio0.99
Quick Ratio0.23
Cash Ratio0.20
Debt / Assets0.18
Debt / Capital0.25
Debt / Equity0.34
Long-Term Debt / Capital0.17
Debt / Market Cap24.64%
Net Debt / EBITDA2.09
Solvency Ratio0.10
Financial Leverage1.86
Efficiency & Working Capital
Asset Turnover0.38
Fixed Asset Turnover4.09
Inventory Turnover0.55
Receivables Turnover5.31
Payables Turnover0.56
Days Sales Outstanding68.69
Days Inventory Outstanding660.88
Days Payables Outstanding646.44
Operating Cycle729.57
Cash Conversion Cycle83.13
Working Capital Turnover-388.25
Returns & Quality
Return on Equity5.52%
Return on Assets3.07%
Return on Invested Capital7.41%
ROCE10.37%
Return on Tangible Assets6.52%
Operating Return on Assets7.83%
Income Quality2.07
Tax Burden0.76
Interest Burden0.84
Balance Sheet & Intrinsic Metrics
Enterprise Value$105.18B
Invested Capital$79.86B
Working Capital$-408M
Tangible Asset Value$1.25B
Net Current Asset Value$-27.97B
Graham Number$65.61
Graham Net-Net-$14.28
Book Value / Share$29.07
Tangible Book Value / Share$0.52
Cash / Share$2.65
Financial Health Scores
Piotroski Score7
Altman Z-Score1.49
Revenue$48.92B
EBIT$8.89B
Market Cap$88.28B
Working Capital$-408M
Retained Earnings$0
Total Assets$129.06B
Total Liabilities$59.49B